Cubist Pharmaceuticals Inc (CBST)
Drugs are bad. Just say no to drugs. Unless they're legal and they're going to help you overcome pain or some other disease. That's at the core of Cubist's business — their drugs treat skin diseases and infections.
| Yearly Income Statement | 2011 Annual |
|---|---|
|
All the money that a company makes from selling their products or services. Kind of like your salary. 
Total Revenue
|
$753.97m |
|
What companies get to keep after paying for the costs of selling their product. So if you sell lemonade for $1 and it costs you 50 cents to make, your gross profit is 50 cents.
Gross Profit
|
$581.11m |
|
The money they generate solely from their core business. So the money you make at a garage sale doesn't count, but your salary does.
Operating Income
|
$241.45m |
|
The bottom line -- what they get to keep after paying all of their expenses. It's what's left of your salary after paying for your needs that you can put towards your wants.
Net Income
|
$33.02m |
| Balance Sheet | |
|
Everything a company has that will be turned into cash within a year. This includes things like inventory or money they are owed.
Total Current Assets
|
$1.04b |
|
All the stuff the company needs to pay off within a year. It's basically the opposite of total current assets.
Total Current Liabilities
|
$252.39m |
|
Take everything the company owns and subtract what they owe -- it's what belongs to the shareholders. Think of it as your net worth.
Total Equity
|
$799.86m |
| Cash Flow | |
|
The bottom line -- what they get to keep after paying all of their expenses. It's what's left of your salary after paying for your needs that you can put towards your wants.
Net Income/Starting Line
|
$33.02m |
|
The cash that companies make from their core business of selling products or services. If you sell lemonade, it's the cash you make from selling it.
Cash from Operating
|
$200.37m |
|
This is the cash that companies make from their investments. If you invest in a second lemonade stand, this is where it would go.
Cash from Investing
|
$-439.55m |
|
Changes in debt, loans and dividends. If a neighbor owes you for a glass of lemonade you gave him for free or if you owe someone else, it would show up here.
Cash from Financing
|
$62.84m |
|
Has the amount of cash gone up or down? This number shows how much more (or less) they made over time. Are things getting better or worse?
Net Change in Cash
|
$-175.35m |
Events
-
June 72012Cubist Pharmaceuticals Inc., Annual General Meeting, Jun 07, 2012
-
June112012Cubist Pharmaceuticals Inc. - Shareholder/Analyst Call
-
July182012Cubist Pharmaceuticals Inc. expected to report Q2 2012 results on July 18, 2012. This event was calculated by Capital IQ (Created on April 20, 2012).
-
January202013Cubist Pharmaceuticals Inc. expected to report Fiscal Year 2012 results on January 20, 2013. This event was calculated by Capital IQ (Created on January 22, 2012).
-
January202013Cubist Pharmaceuticals Inc. expected to report Fiscal Year 2012 results on January 20, 2013. This event was calculated by Capital IQ (Created on April 21, 2012).
Members who own this company also own
Current price per share
Today's gain: $-0.63 (-1.50%)
